What amount sold does Envision Life Labs LLC report in Form D filings?

The latest linked filings report $0 sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Envision Life Labs LLC's most recent SEC filing?

Envision Life Labs LLC's most recent Form D filing was on 2024-04-09.

What type of securities does Envision Life Labs LLC offer?

Envision Life Labs LLC's SEC Form D filings indicate equity offerings.

Envision Life Labs LLC

CIK: 0001974864·Biotechnology·Cambridge, MA·Limited Liability Company·Founded 2022

Reported Sold

Total Filings

Identified Offerings

Last Filed

Apr 9, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Apr 9, 2024Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 506(c)·0 investors

Apr 24, 2023Form D — New notice

Reported sold: $0 · Target: Indefinite

Rule 506(b)·0 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Thomas J. Cahill

Related Person

Appears on 1 filing

Stephen Pagliuca

Related Person

Appears on 1 filing

Stuart Schreiber

Related Person

Appears on 1 filing

Thomas J Cahill

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 9, 2024	New	Indefinite	$0	0
Apr 24, 2023	New	Indefinite	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Elucid Bioimaging Inc.

Biotechnology

Offering target: $79,999,999

Filed Oct 27, 2026